Cullinan Therapeutics, Inc. (CGEM)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
Key ratios (FY2025)
-53.8%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | $0 | $18.94M | $0 | — |
| Operating Income | -$241.65M | -$196.92M | -$191.09M | $144.65M | -$67.95M | -$60.34M | — |
| Net Income | -$219.88M | -$167.38M | -$153.16M | $111.21M | -$65.57M | -$51.80M | — |
| EPS (Diluted) | — | — | $-3.69 | $2.38 | $-1.52 | — | — |
| Total Assets | $448.37M | $621.82M | $484.18M | $561.12M | $437.19M | $214.71M | — |
| Total Liabilities | $39.64M | $31.50M | $30.29M | $26.09M | $11.81M | $14.39M | — |
| Shareholders' Equity | $408.73M | $590.33M | $453.70M | $535.03M | $424.97M | $199.01M | $97.00M |
| Cash & Equivalents | $88.33M | $83.00M | $98.43M | $156.15M | $59.77M | $168.20M | — |
| Operating Cash Flow | -$175.75M | -$145.30M | -$134.28M | -$126.66M | -$43.43M | -$29.77M | — |
| Capital Expenditures | $49.0K | $0 | $208.0K | $1.13M | $0 | $10.0K | — |
| Shares Outstanding | 60.24M | 58.51M | 42.90M | 45.80M | 44.29M | 29.83M | — |